Generics - Lupin

Filter

Current filters:

Lupin

Popular Filters

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

India’s Lupin launches insulin glargine analogue Basugine

11-08-2014

Indian generic drugmaker Lupin has entered into a strategic distribution agreement with LG Life Sciences…

BasugineBiosimilarsDiabetesGenericsIndiaLantusLG Life SciencesLupinMarkets & MarketingPeptide hormonesRecombinant proteinsSanofi

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

European Generic Medicines Association speaks out against EC’s perindopril decision

European Generic Medicines Association speaks out against EC’s perindopril decision

09-07-2014

The European Generic Medicines Association (EGA) has expressed concerns over the European Commission’s…

Cardio-vascularEuropeGenericsLegalLupinperindoprilServierunichem

Lupin no longer trying to market generics of Truvada and Viread

Lupin no longer trying to market generics of Truvada and Viread

08-06-2014

Indian drugmaker Lupin seems to have abandoned plans to bring to market generic versions of Gilead Sciences’…

Anti-viralsGenericsGilead SciencesLegalLupinPatentsTruvadaUSAViread

Lupin launches generic Niaspan in USA

24-03-2014

Indian drugmaker Lupin says that its US subsidiary has launched its niacin extended-release tablets USP,…

AbbVieCardio-vascularGenericsLupinMarkets & MarketingNiaspanNorth AmericaUSA

Mixed US court decision on ViiV Healthcare’s Epzicom and Trizivir patents

19-12-2013

UK pharma giant GlaxoSmithKline and ViiV Healthcare confirmed that the US District Court for the District…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalLupinPatentsTeva Pharmaceutical IndustriesTrizivirViiV Healthcare

US FDA approves generics for Actavis and Lupin

06-07-2012

Switzerland-based generic drugmaker Actavis Group, now owned by US firm Watson Pharmaceuticals (NYSE:…

ActavisGenericsIntunivLupinLyricaNeurologicalNorth AmericaPfizerRegulationShireWatson Pharmaceuticals

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top